Current Report Filing (8-k)
June 05 2017 - 3:26PM
Edgar (US Regulatory)
SECURITIES AND EXCHANGE
COMMISSION
Washington, D.C. 20549
FORM 8-K CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of
Report (Date of earliest event reported): June 1, 2017
YOUNGEVITY INTERNATIONAL, INC.
(Exact
name of registrant as specified in its charter)
Delaware
|
|
000-54900
|
|
90-0890517
|
(State
or other jurisdiction of incorporation)
|
|
(Commission
File No.)
|
|
(IRS
Employer Identification No.)
|
2400
Boswell Road, Chula Vista, CA 91914
(Address
of principal executive offices) (Zip Code)
Registrant’s
telephone number, including area code: (619) 934-3980
N/A
(Former
name or former address, if changed since last report)
Check
the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
☐
Written communications pursuant to Rule 425 under the Securities
Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act
(17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
Indicate
by check mark whether the registrant is an emerging growth company
as defined in in Rule 405 of the Securities Act of 1933
(§230.405 of this chapter) or Rule 12b-2 of the Securities
Exchange Act of 1934 (§240.12b-2 of this
chapter).
Emerging growth
company ☑
|
|
If an
emerging growth company, indicate by checkmark if the registrant
has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided
pursuant to Section 13(a) of the Exchange Act.
☐
Item 5.02. Departure of Directors or Certain Officers; Election of
Directors;
Appointment of
Certain Officers; Compensatory Arrangements of Certain
Officers.
On June
1, 2017, the Board of Directors of Youngevity International, Inc.
(the “Company”) appointed Paul Sallwasser and Kevin
Allodi to the Board of Directors (the
“Board”). Each of Mr. Sallwasser and Mr. Allodi
were also appointed to serve on the Audit Committee of the
Board.
Neither
Messrs. Sallwasser nor Allodi were selected as a director pursuant
to any arrangements or understandings with the Company or with any
other person. Additionally, there have been no
transactions involving Messrs. Sallwasser and Allodi that would
require disclosure under Item 404(a) of Regulation
S-K.
On June
5, 2017, the Company issued a press release announcing the
appointment of Messrs. Sallwasser and Allodi as directors of the
Company. A copy of the press release is attached as Exhibit 99.1 to
this Current Report on Form 8-K.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
The
following exhibit is being filed as part of this Current Report on
Form 8-K.
Exhibit
Number
|
Description
|
|
|
99.1
|
Press
Release, dated June 5, 2017
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
|
YOUNGEVITY
INTERNATIONAL, INC.
|
|
|
Date:
June 5, 2017
|
By:
/s/ David
Briskie
|
|
Name:
David Briskie
|
|
Title:
President and Chief Financial Officer
|
EXHIBIT INDEX
Exhibit No
.
|
Exhibits.
|
|
|
99.1
|
Press
Release issued by Youngevity International, Inc. dated June 5,
2017
|
Youngevity (NASDAQ:YGYI)
Historical Stock Chart
From Aug 2024 to Sep 2024
Youngevity (NASDAQ:YGYI)
Historical Stock Chart
From Sep 2023 to Sep 2024